Joint Formulary & PAD

Remimazolam - Concious sedation / procedural sedation

You are here : Home > Formulary Search > Remimazolam - Concious sedation / procedural sedation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Remimazolam
Indication :
Concious sedation / procedural sedation
Group Name :
Keywords :
Brand Names Include :
Important Information :

SASH Restriction: Adults Special Care Dentistry for indications below: - Frail older adults. - ASA3 medically complex patients, - Patients with severe cognitive disorders, - Complex oral surgery patients, - Patients with severe LD or ASD for whom a fast recovery makes care safer.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.

Other Indications

Below are listed other indications that Remimazolam is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Concious sedation / procedural sedation.